-
1
-
-
0029737381
-
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
-
Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
-
(1996)
N Engl J Med
, vol.335
, pp. 462-467
-
-
Walsh, T.N.1
Noonan, N.2
Hollywood, D.3
-
2
-
-
19044377750
-
American Gastroenterological Association medical position statement. role of the gastroenterologist in the management of esophageal carcinoma
-
Wang K.K., Wongkeesong M., and Buttar N.S. American Gastroenterological Association medical position statement. role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology 128 (2005) 1468-1470
-
(2005)
Gastroenterology
, vol.128
, pp. 1468-1470
-
-
Wang, K.K.1
Wongkeesong, M.2
Buttar, N.S.3
-
3
-
-
18844382358
-
Advances in Barrett's esophagus and Esophageal adenocarcinoma
-
Shaheen N.J. Advances in Barrett's esophagus and Esophageal adenocarcinoma. Gastroenterology 128 (2005) 1554-1566
-
(2005)
Gastroenterology
, vol.128
, pp. 1554-1566
-
-
Shaheen, N.J.1
-
4
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
-
5
-
-
0003964363
-
-
American Cancer Society, American Cancer Society, Atlanta
-
American Cancer Society. Cancer facts & figures (2005), American Cancer Society, Atlanta
-
(2005)
Cancer facts & figures
-
-
-
6
-
-
21244467485
-
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk
-
Schulmann K., Sterian A., Berki A., et al. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 24 (2005) 4138-4148
-
(2005)
Oncogene
, vol.24
, pp. 4138-4148
-
-
Schulmann, K.1
Sterian, A.2
Berki, A.3
-
7
-
-
16544395591
-
DNA methylation and cancer
-
Das P.M., and Singal R. DNA methylation and cancer. J Clin Oncol 22 (2004) 4632-4642
-
(2004)
J Clin Oncol
, vol.22
, pp. 4632-4642
-
-
Das, P.M.1
Singal, R.2
-
8
-
-
0242539836
-
Cancer epigenetics
-
Momparler R.L. Cancer epigenetics. Oncogene 22 (2003) 6479-6483
-
(2003)
Oncogene
, vol.22
, pp. 6479-6483
-
-
Momparler, R.L.1
-
9
-
-
0035870280
-
Epigenetic patterns in the progression of esophageal adenocarcinoma
-
Eads C.A., Lord R.V., Wickramasinghe K., et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61 (2001) 3410-3418
-
(2001)
Cancer Res
, vol.61
, pp. 3410-3418
-
-
Eads, C.A.1
Lord, R.V.2
Wickramasinghe, K.3
-
10
-
-
0036894567
-
Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma
-
Sato F., Shibata D., Harpaz N., et al. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Cancer Res 62 (2002) 6820-6822
-
(2002)
Cancer Res
, vol.62
, pp. 6820-6822
-
-
Sato, F.1
Shibata, D.2
Harpaz, N.3
-
11
-
-
20844443467
-
Aberrant methylation of Reprimo in human malignancies
-
Takahashi T., Suzuki M., Shigematsu H., et al. Aberrant methylation of Reprimo in human malignancies. Int J Cancer 115 (2005) 503-510
-
(2005)
Int J Cancer
, vol.115
, pp. 503-510
-
-
Takahashi, T.1
Suzuki, M.2
Shigematsu, H.3
-
12
-
-
12444268993
-
Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma
-
Brock M.V., Gou M., Akiyama Y., et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 9 (2003) 2912-2919
-
(2003)
Clin Cancer Res
, vol.9
, pp. 2912-2919
-
-
Brock, M.V.1
Gou, M.2
Akiyama, Y.3
-
13
-
-
18644384743
-
Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma. loss of expression correlates with poor prognosis
-
Darnton S.J., Hardie L.J., Muc R.S., et al. Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma. loss of expression correlates with poor prognosis. Int J Cancer 115 (2005) 351-358
-
(2005)
Int J Cancer
, vol.115
, pp. 351-358
-
-
Darnton, S.J.1
Hardie, L.J.2
Muc, R.S.3
-
14
-
-
0034669126
-
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
-
Kawakami K., Brabender J., Lord R.V., et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 92 (2000) 1805-1811
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1805-1811
-
-
Kawakami, K.1
Brabender, J.2
Lord, R.V.3
-
15
-
-
20244390458
-
Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer
-
Kikuchi S., Yamada D., Fukami T., et al. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Clin Cancer Res 11 (2005) 2954-2961
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2954-2961
-
-
Kikuchi, S.1
Yamada, D.2
Fukami, T.3
-
16
-
-
21144456526
-
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma
-
Catto J.W., Azzouzi A.R., Rehman I., et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 23 (2005) 2903-2910
-
(2005)
J Clin Oncol
, vol.23
, pp. 2903-2910
-
-
Catto, J.W.1
Azzouzi, A.R.2
Rehman, I.3
-
17
-
-
20144365156
-
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer
-
Martens J.W., Nimmrich I., Koenig T., et al. Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res 65 (2005) 4101-4117
-
(2005)
Cancer Res
, vol.65
, pp. 4101-4117
-
-
Martens, J.W.1
Nimmrich, I.2
Koenig, T.3
-
18
-
-
13944250245
-
Circulating tumor-specific DNA. a marker for monitoring efficacy of adjuvant therapy in cancer patients
-
Fiegl H., Millinger S., Mueller-Holzner E., et al. Circulating tumor-specific DNA. a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res 65 (2005) 1141-1145
-
(2005)
Cancer Res
, vol.65
, pp. 1141-1145
-
-
Fiegl, H.1
Millinger, S.2
Mueller-Holzner, E.3
-
19
-
-
0028224017
-
Radiation response of mouse lymphoid and myeloid cell lines. Part I. Sensitivity to killing by ionizing radiation, rate of loss of viability, and cell type of origin
-
Radford I.R. Radiation response of mouse lymphoid and myeloid cell lines. Part I. Sensitivity to killing by ionizing radiation, rate of loss of viability, and cell type of origin. Int J Radiat Biol 65 (1994) 203-215
-
(1994)
Int J Radiat Biol
, vol.65
, pp. 203-215
-
-
Radford, I.R.1
-
20
-
-
0028220486
-
Radiation response of mouse lymphoid and myeloid cell lines. Part II. Apoptotic death is shown by all lines examined
-
Radford I.R., Murphy T.K., Radley J.M., et al. Radiation response of mouse lymphoid and myeloid cell lines. Part II. Apoptotic death is shown by all lines examined. Int J Radiat Biol 65 (1995) 217-227
-
(1995)
Int J Radiat Biol
, vol.65
, pp. 217-227
-
-
Radford, I.R.1
Murphy, T.K.2
Radley, J.M.3
-
21
-
-
0035527317
-
New concepts in radiation-induced apoptosis. 'premitotic apoptosis' and 'postmitotic apoptosis'
-
Shinomiya N. New concepts in radiation-induced apoptosis. 'premitotic apoptosis' and 'postmitotic apoptosis'. J Cell Mol Med 5 (2001) 240-253
-
(2001)
J Cell Mol Med
, vol.5
, pp. 240-253
-
-
Shinomiya, N.1
-
22
-
-
0034725694
-
Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase
-
Ohki R., Nemoto J., Murasawa H., et al. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J Biol Chem 275 (2000) 22627-22630
-
(2000)
J Biol Chem
, vol.275
, pp. 22627-22630
-
-
Ohki, R.1
Nemoto, J.2
Murasawa, H.3
-
23
-
-
0034626988
-
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
-
Esteller M., Garcia-Foncillas J., Andion E., et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343 (2000) 1350-1354
-
(2000)
N Engl J Med
, vol.343
, pp. 1350-1354
-
-
Esteller, M.1
Garcia-Foncillas, J.2
Andion, E.3
-
24
-
-
0037148527
-
The checkpoint protein CHFR is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition
-
Kang D., Chen J., Wong J., et al. The checkpoint protein CHFR is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition. J Cell Biol 156 (2002) 249-259
-
(2002)
J Cell Biol
, vol.156
, pp. 249-259
-
-
Kang, D.1
Chen, J.2
Wong, J.3
-
25
-
-
0036799843
-
CHFR expression is downregulated by CpG island hypermethylation in esophageal cancer
-
Shibata Y., Haruki N., Kuwabara Y., et al. CHFR expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis 23 (2002) 1695-1699
-
(2002)
Carcinogenesis
, vol.23
, pp. 1695-1699
-
-
Shibata, Y.1
Haruki, N.2
Kuwabara, Y.3
-
26
-
-
16544378577
-
Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas
-
Kobatake T., Yano M., Toyooka S., et al. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep 12 (2004) 1087-1092
-
(2004)
Oncol Rep
, vol.12
, pp. 1087-1092
-
-
Kobatake, T.1
Yano, M.2
Toyooka, S.3
-
27
-
-
0037108915
-
Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas
-
Shibata D.M., Sato F., Mori Y., et al. Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas. Cancer Res 62 (2002) 5637-5640
-
(2002)
Cancer Res
, vol.62
, pp. 5637-5640
-
-
Shibata, D.M.1
Sato, F.2
Mori, Y.3
-
28
-
-
0035793108
-
HPP1. a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers
-
Young J., Biden K.G., Simms L.A., et al. HPP1. a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci U S A 98 (2001) 265-270
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 265-270
-
-
Young, J.1
Biden, K.G.2
Simms, L.A.3
-
29
-
-
33744744831
-
-
Shibata D, Zhang L, Cai K, et al. Tumor suppressor effects of HPP1 overexpression in colon cancer. Gastroenterology 2005;128:a-787.
-
-
-
-
30
-
-
0043063959
-
Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers
-
Masuda N., Kato H., Nakajima T., et al. Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers. Cancer Sci 94 (2003) 612-617
-
(2003)
Cancer Sci
, vol.94
, pp. 612-617
-
-
Masuda, N.1
Kato, H.2
Nakajima, T.3
-
31
-
-
0034092061
-
Molecular alterations of p73 in human esophageal squamous cell carcinomas. loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53
-
Cai Y.C., Yang G.Y., Nie Y., et al. Molecular alterations of p73 in human esophageal squamous cell carcinomas. loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 21 (2000) 683-689
-
(2000)
Carcinogenesis
, vol.21
, pp. 683-689
-
-
Cai, Y.C.1
Yang, G.Y.2
Nie, Y.3
-
32
-
-
5644255657
-
The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma
-
Maley C.C., Galipeau P.C., Li X., et al. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res 64 (2004) 7629-7633
-
(2004)
Cancer Res
, vol.64
, pp. 7629-7633
-
-
Maley, C.C.1
Galipeau, P.C.2
Li, X.3
-
33
-
-
4444320783
-
Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus
-
Heeren P.A., Kloppenberg F.W., Hollema H., et al. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus. Anticancer Res 24 (2004) 2579-2583
-
(2004)
Anticancer Res
, vol.24
, pp. 2579-2583
-
-
Heeren, P.A.1
Kloppenberg, F.W.2
Hollema, H.3
-
34
-
-
0036545242
-
Molecular and biologic basis of upper gastrointestinal malignancy. esophageal carcinoma
-
viii
-
Souza R.F. Molecular and biologic basis of upper gastrointestinal malignancy. esophageal carcinoma. Surg Oncol Clin N Am 11 (2002) 257-272 viii
-
(2002)
Surg Oncol Clin N Am
, vol.11
, pp. 257-272
-
-
Souza, R.F.1
-
36
-
-
0029048745
-
Apoptosis and the cell cycle
-
Meikrantz W., and Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 58 (1995) 160-174
-
(1995)
J Cell Biochem
, vol.58
, pp. 160-174
-
-
Meikrantz, W.1
Schlegel, R.2
-
37
-
-
0037790592
-
Apoptosis and interferons. role of interferon-stimulated genes as mediators of apoptosis
-
Chawla-Sarkar M., Lindner D.J., Liu Y.F., et al. Apoptosis and interferons. role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8 (2003) 237-249
-
(2003)
Apoptosis
, vol.8
, pp. 237-249
-
-
Chawla-Sarkar, M.1
Lindner, D.J.2
Liu, Y.F.3
-
38
-
-
0035866790
-
Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells
-
Akhtar M., Cheng Y., Magno R.M., et al. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res 61 (2001) 2399-2403
-
(2001)
Cancer Res
, vol.61
, pp. 2399-2403
-
-
Akhtar, M.1
Cheng, Y.2
Magno, R.M.3
-
39
-
-
18144406143
-
Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells
-
Yang X., Xing H., Gao Q., et al. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells. Gynecol Oncol 97 (2005) 413-421
-
(2005)
Gynecol Oncol
, vol.97
, pp. 413-421
-
-
Yang, X.1
Xing, H.2
Gao, Q.3
-
40
-
-
20344377602
-
Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy
-
Pyo H., Kim Y.B., Cho N.H., et al. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 725-732
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.62
, pp. 725-732
-
-
Pyo, H.1
Kim, Y.B.2
Cho, N.H.3
-
41
-
-
0028241332
-
Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas
-
Meltzer S.J., Yin J., Manin B., et al. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res 54 (1994) 3379-3382
-
(1994)
Cancer Res
, vol.54
, pp. 3379-3382
-
-
Meltzer, S.J.1
Yin, J.2
Manin, B.3
-
42
-
-
0036210281
-
p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus
-
Bian Y.S., Osterheld M.C., Fontolliet C., et al. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology 122 (2002) 1113-1121
-
(2002)
Gastroenterology
, vol.122
, pp. 1113-1121
-
-
Bian, Y.S.1
Osterheld, M.C.2
Fontolliet, C.3
-
44
-
-
2442567836
-
Inactivation mechanisms and growth suppressive effects of p16INK4a in Asian esophageal squamous carcinoma cell lines
-
Kwong F.M., Tang J.C., Srivastava G., et al. Inactivation mechanisms and growth suppressive effects of p16INK4a in Asian esophageal squamous carcinoma cell lines. Cancer Lett 208 (2004) 207-213
-
(2004)
Cancer Lett
, vol.208
, pp. 207-213
-
-
Kwong, F.M.1
Tang, J.C.2
Srivastava, G.3
-
45
-
-
0142258073
-
The tumor-suppressive functions of the human INK4A locus
-
Voorhoeve P.M., and Agami R. The tumor-suppressive functions of the human INK4A locus. Cancer Cell 4 (2003) 311-319
-
(2003)
Cancer Cell
, vol.4
, pp. 311-319
-
-
Voorhoeve, P.M.1
Agami, R.2
-
46
-
-
0033622003
-
p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
-
Carnero A., Hudson J.D., Price C.M., et al. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2 (2000) 148-155
-
(2000)
Nat Cell Biol
, vol.2
, pp. 148-155
-
-
Carnero, A.1
Hudson, J.D.2
Price, C.M.3
-
47
-
-
0031451923
-
Relationships between p53 induction, cell cycle arrest and survival of normal human fibroblasts following DNA damage
-
Ceraline J., Deplanque G., Duclos B., et al. Relationships between p53 induction, cell cycle arrest and survival of normal human fibroblasts following DNA damage. Bull Cancer 84 (1997) 1007-1016
-
(1997)
Bull Cancer
, vol.84
, pp. 1007-1016
-
-
Ceraline, J.1
Deplanque, G.2
Duclos, B.3
-
48
-
-
0032209765
-
Radiation and the G2 phase of the cell cycle
-
Hwang A., and Muschel R.J. Radiation and the G2 phase of the cell cycle. Radiat Res 150 (1998) S52-S59
-
(1998)
Radiat Res
, vol.150
-
-
Hwang, A.1
Muschel, R.J.2
-
49
-
-
0034721154
-
CHFR defines a mitotic stress checkpoint that delays entry into metaphase
-
Scolnick D.M., and Halazonetis T.D. CHFR defines a mitotic stress checkpoint that delays entry into metaphase. Nature 406 (2000) 430-435
-
(2000)
Nature
, vol.406
, pp. 430-435
-
-
Scolnick, D.M.1
Halazonetis, T.D.2
-
50
-
-
9144239265
-
Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer
-
Satoh A., Toyota M., Itoh F., et al. Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res 63 (2003) 8606-8613
-
(2003)
Cancer Res
, vol.63
, pp. 8606-8613
-
-
Satoh, A.1
Toyota, M.2
Itoh, F.3
-
51
-
-
0037275750
-
Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene CHFR in colorectal and non-small cell lung cancer
-
Corn P.G., Summers M.K., Fogt F., et al. Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene CHFR in colorectal and non-small cell lung cancer. Carcinogenesis 24 (2003) 47-51
-
(2003)
Carcinogenesis
, vol.24
, pp. 47-51
-
-
Corn, P.G.1
Summers, M.K.2
Fogt, F.3
-
52
-
-
0038687773
-
Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma
-
Zhang L., Lu W., Miao X., et al. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis 24 (2003) 1039-1044
-
(2003)
Carcinogenesis
, vol.24
, pp. 1039-1044
-
-
Zhang, L.1
Lu, W.2
Miao, X.3
-
53
-
-
0036005894
-
Inactivation of O6-methylguanine-DNA methyltransferase in human lung adenocarcinoma relates to high-grade histology and worse prognosis among smokers
-
Hayashi H., Yazawa T., Okudela K., et al. Inactivation of O6-methylguanine-DNA methyltransferase in human lung adenocarcinoma relates to high-grade histology and worse prognosis among smokers. Jpn J Cancer Res 93 (2002) 184-189
-
(2002)
Jpn J Cancer Res
, vol.93
, pp. 184-189
-
-
Hayashi, H.1
Yazawa, T.2
Okudela, K.3
-
54
-
-
7944231990
-
An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma
-
Miyazaki T., Kato H., Nakajima M., et al. An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma. Br J Cancer 91 (2004) 1556-1560
-
(2004)
Br J Cancer
, vol.91
, pp. 1556-1560
-
-
Miyazaki, T.1
Kato, H.2
Nakajima, M.3
-
55
-
-
0032900181
-
Combination of taxanes with radiation. preclinical studies
-
Milas L., Milas M.M., and Mason K.A. Combination of taxanes with radiation. preclinical studies. Semin Radiat Oncol 9 (1999) 12-26
-
(1999)
Semin Radiat Oncol
, vol.9
, pp. 12-26
-
-
Milas, L.1
Milas, M.M.2
Mason, K.A.3
-
56
-
-
19444383072
-
The molecular mechanisms of oesophageal cancer
-
McCabe M.L., and Dlamini Z. The molecular mechanisms of oesophageal cancer. Int Immunopharmacol 5 (2005) 1113-1130
-
(2005)
Int Immunopharmacol
, vol.5
, pp. 1113-1130
-
-
McCabe, M.L.1
Dlamini, Z.2
-
57
-
-
20144372603
-
Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy
-
Ghadimi B.M., Grade M., Difilippantonio M.J., et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23 (2005) 1826-1838
-
(2005)
J Clin Oncol
, vol.23
, pp. 1826-1838
-
-
Ghadimi, B.M.1
Grade, M.2
Difilippantonio, M.J.3
|